Global Point-of-care Molecular Diagnostics Market Size & Outlook
Global point-of-care molecular diagnostics market, 2018-2030 (US$M)
Related Markets
Global point-of-care molecular diagnostics market highlights
- The global point-of-care molecular diagnostics market generated a revenue of USD 5,174.8 million in 2023 and is expected to reach USD 7,087.6 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 4.6% by 2030.
- In terms of segment, infectious diseases accounted for a revenue of USD 4,839.3 million in 2023.
- Oncology is the most lucrative application segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Kuwait is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 5,174.8 million |
| Market revenue in 2030 | USD 7,087.6 million |
| Growth rate | 4.6% (CAGR from 2023 to 2030) |
| Largest segment | Infectious diseases |
| Fastest growing segment | Oncology |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oncology, Prenatal Testing, Endocrinology, Other Applications, Hematology, Infectious Diseases |
Other key industry trends
- In terms of revenue, the North America accounted for 45.4% of the global point-of-care molecular diagnostics market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Kuwait is the fastest growing regional market and is projected to reach USD 14.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Point-of-Care Molecular Diagnostics Market Scope
Point-of-Care Molecular Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global point-of-care molecular diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care molecular diagnostics market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 93.52% in 2023. Horizon Databook has segmented the Global point-of-care molecular diagnostics market based on oncology, prenatal testing, endocrinology, other applications, hematology, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Point-of-Care Molecular Diagnostics Application Outlook (Revenue, USD Million, 2018-2030)
- Oncology
- Prenatal Testing
- Endocrinology
- Other Applications
- Hematology
- Complete blood count (CBC)
- Prothrombin time (PT)
- Partial Thromboplastin Time (PTT)
- Others
- Infectious Diseases
- CT/NG
- HIV POC
- Clostridium difficile POC
- HBV POC
- Pneumonia or Streptococcus associated infections
- Respiratory syncytial virus (RSV) POC
- HPV POC
- Influenza/Flu POC
- HCV POC
- MRSA POC
- TB and drug-resistant TB POC
- HSV POC
- COVID-19
- Other Infectious Diseases
- Global Point-of-Care Molecular Diagnostics Technology Outlook (Revenue, USD Million, 2018-2030)
- PCR-based
- Genetic Sequencing based
- Hybridization based
- Microarray based
- Global Point-of-Care Molecular Diagnostics Test Location Outlook (Revenue, USD Million, 2018-2030)
- OTC
- POC
- Global Point-of-Care Molecular Diagnostics End Use Outlook (Revenue, USD Million, 2018-2030)
- Decentralised Labs
- Hospitals
- Home care
- Assisted Living Healthcare Facilities
- Others
Reasons to subscribe to Global point-of-care molecular diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global point-of-care molecular diagnostics market databook
-
Our clientele includes a mix of point-of-care molecular diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global point-of-care molecular diagnostics market , including forecasts for subscribers. This global databook contains high-level insights into Global point-of-care molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global point-of-care molecular diagnostics market size, by regions, 2018-2030 (US$M)
Top 10 countries: Point-of-care molecular diagnostics market size, 2023 (US$M)
Global point-of-care molecular diagnostics market share, by application, 2023 & 2030 (%, US$M)
Point-of-care molecular diagnostics market: Opportunity assessment by country
Global point-of-care molecular diagnostics market, by region, 2023 (US$M)
| Application | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 915.4 | 1,059.9 | 2,343.5 | 2,867.7 | 3,963.0 | 2,350.9 | 2,492.4 | 2,622.0 | 2,739.5 | 2,844.9 | 2,938.4 | 3,020.7 | 3,092.2 | 4.0% |
| Europe | 512.7 | 598.4 | 1,333.9 | 1,645.7 | 2,293.2 | 1,371.8 | 1,466.7 | 1,556.2 | 1,639.9 | 1,717.9 | 1,790.1 | 1,856.7 | 1,917.8 | 4.9% |
| Asia Pacific | 385.0 | 453.3 | 1,019.4 | 1,269.0 | 1,784.2 | 1,077.1 | 1,162.2 | 1,244.7 | 1,324.1 | 1,400.3 | 1,473.2 | 1,542.8 | 1,609.3 | 5.9% |
| Latin America | 85.2 | 98.3 | 216.3 | 263.7 | 363.0 | 214.5 | 226.5 | 237.2 | 246.9 | 255.3 | 262.6 | 268.8 | 274.0 | 3.6% |
| MEA | 66.0 | 75.7 | 165.5 | 200.3 | 273.7 | 160.5 | 168.2 | 174.9 | 180.6 | 185.4 | 189.2 | 192.2 | 194.4 | 2.8% |
| Overall | 1,964.2 | 2,285.6 | 5,078.7 | 6,246.4 | 8,677.1 | 5,174.8 | 5,516.0 | 5,835.0 | 6,131.0 | 6,403.8 | 6,653.5 | 6,881.1 | 7,087.6 | 4.6% |
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
